Beckman coulter's sars-cov-2 igg ii antibody test receives emergency use authorization from the fda

Brea, calif., march 23, 2021 /prnewswire/ -- beckman coulter, a clinical diagnostics leader, today announced that its access sars-cov-2 igg ii antibody assay received u.s. emergency use authorization (eua) from the u.s. food and drug administration.
DHR Ratings Summary
DHR Quant Ranking